+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis



Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis



European Child and Adolescent Psychiatry 2018



This meta-analysis was conducted to evaluate the association between Attention deficit hyperactivity disorder (ADHD) medications and risk of sudden death/arrhythmia, stroke, myocardial infarction as well as all-cause death. We searched PubMed, Web of Science and China National Knowledge Infrastructure from 1950 to May 2018. All observational studies that the exposure of interest was ADHD medications, the outcome of interest was sudden death/arrhythmia, stroke, myocardial infarction as well as all-cause death, and the study reported relative risks (RRs) with 95% confidence intervals (95% CIs) were included. Pooled RRs were estimated by random-effects model. Subgroup analyses were conducted to examine the effects of study design, population, Country, follow-up duration, female proportion, covariates adjustment on the risk of sudden death/arrhythmia. Eight articles with ten studies (4,221,929 participants) were included in this meta-analysis about the association between ADHD medications and risk of sudden death/arrhythmia. The pooled RRs with 95% CIs of sudden death/arrhythmia for ADHD medications were 1.39 (1.06, 1.83). The result of the cohort study was 1.24 (0.84, 1.83). The pooled RRs between ADHD medications and stroke, myocardial infarction, all-cause death were 1.00 (0.74, 1.35), 0.91 (0.79, 1.05), 0.89 (0.54, 1.45), respectively. As for methylphenidate, the pooled RRs between methylphenidate and sudden death/arrhythmia, stroke, myocardial infarction, all-cause death were 1.46 (1.03, 2.07), 0.92 (0.70, 1.21), 0.97 (0.77, 1.23), 1.00 (0.49, 2.04), respectively. Based on the results of cohort studies, there was no correlation between ADHD medications and sudden death/arrhythmia, stroke, myocardial infarction and all-cause death. However, some of the confidence intervals do not exclude modest elevated risks, e.g., for sudden death/arrhythmia.

(PDF emailed within 0-6 h: $19.90)

Accession: 050960858

Download citation: RISBibTeXText

PMID: 30143889

DOI: 10.1007/s00787-018-1217-x


Related references

Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews 84: 63-71, 2017

Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: protocol for a systematic review and meta-analysis. Bmj Open 7(9): E018027, 2018

Association between berries intake and cardiovascular diseases risk factors: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Food and Function 9(2): 740-757, 2017

Dietary Inflammatory Index and its Association with the Risk of Cardiovascular Diseases, Metabolic Syndrome, and Mortality: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research 50(5): 345-358, 2018

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opinion on Drug Safety 13(10): 1327-1351, 2015

Association of Grip Strength With Risk of All-Cause Mortality, Cardiovascular Diseases, and Cancer in Community-Dwelling Populations: A Meta-analysis of Prospective Cohort Studies. Journal of the American Medical Directors Association 18(6): 551.E17-551.E35, 2018

ADHD medications and cardiovascular risk: some heartening news. JAMA 306(24): 2723-2724, 2011

Comparing the efficacy of medications for ADHD using meta-analysis. Medgenmed 8(4): 4, 2007

Association between ideal cardiovascular health metrics and risk of cardiovascular events or mortality: A meta-analysis of prospective studies. Clinical Cardiology 40(12): 1339-1346, 2017

Association between subjective social status and cardiovascular disease and cardiovascular risk factors: a systematic review and meta-analysis. Bmj Open 6(3): E010137, 2016

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306(24): 2673-2683, 2011

Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics 136(6): 1144-1153, 2016

Are ADHD medications under or over prescribed worldwide?: Protocol for a systematic review and meta-analysis. Medicine 97(24): E10923, 2018

Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications. Journal of Population Therapeutics and Clinical Pharmacology 21(3): E357-E369, 2015

Association of Motoric Cognitive Risk Syndrome with Cardiovascular Disease and Risk Factors: Results from an Original Study and Meta-Analysis. Journal of Alzheimer's Disease 64(3): 875-887, 2018